Silencing of ELK1 by siRNA inhibits the migration and invasion abilities of cervical cancer cells and regulates ELK1, p‐ELK1, C‐fos, Cyclin D1, and Bcl‐2 expression in vitro. This evidence concerns the gene BCL2 and cervical carcinoma.